Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy
NCT00791570
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Neovascular Maculopathy
Age Related Macular Degeneration
Interventions
BIOLOGICAL:
VEGFR1 and VEGFR2
Sponsor
Osaka University
Collaborators
[object Object]